Agree,
While I would have liked to see much better presentation and communication a long time ago, it is clear their focus is in the right place currently. At this point we just have to be patient with their development process and the time it requires. Billion dollar drugs don't just happen overnight, especially to small microcap companies.
Any type of drug with this preclinical profile has the potential to be transformative, potentially "gold-standard". All stakeholders are in this thing together whether you wanted to be or not. And hopefully we are eventually richly rewarded for our continued support.
Bullish
Market Data 
Markets 
